Dopamine d2 Receptor anticorps (3rd Cytoplasmic Domain)

N° du produit ABIN1733733

Cet anticorps anti-Dopamine d2 Receptor est un anticorps Lapin Polyclonal détectant Dopamine d2 Receptor dans IHC (p). Adapté pour Humain et Singe.

Aperçu rapide pour Dopamine d2 Receptor anticorps (3rd Cytoplasmic Domain) (ABIN1733733)

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Reactivité: Humain, Singe

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Dopamine d2 Receptor est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Détail du produit anti-Dopamine d2 Receptor anticorps

Épitope: 3rd Cytoplasmic Domain

Specificité: Reacts with human DRD2

Réactivité croisée (Details): BLAST analysis of the peptide immunogen showed no homology with other human proteins, except ZNF57 (42 % ).

Purification: Antigen affinity purified

Immunogène: Synthetic 19 amino acid peptide from 3rd cytoplasmic domain of human DRD2. Percent identity with other species by BLAST analysis: Human, Chimpanzee, Gorilla, Marmoset (100%), Gibbon, Monkey, Rabbit (95%), Dog, Bovine, Panda, Horse, Pig (89%), Mouse, Rat, Ferret, Bat, Hamster, Elephant (84%)

Isotype: IgG

Information d'application

Indications d'application:

Working dilution: IHC - P (3 μg/mL - 4

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS, Sodium azide 0.1 %

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C/-80 °C

Stockage commentaire: Long term: -70°C, Short term: +4°C

Détails sur Dopamine d2 Receptor

Antigène: Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))

Autre désignation: Dopamine D2 Receptor

Pathways: Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity